CH532015A - Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen - Google Patents

Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen

Info

Publication number
CH532015A
CH532015A CH1843568A CH1843568A CH532015A CH 532015 A CH532015 A CH 532015A CH 1843568 A CH1843568 A CH 1843568A CH 1843568 A CH1843568 A CH 1843568A CH 532015 A CH532015 A CH 532015A
Authority
CH
Switzerland
Prior art keywords
alkylaminopropanes
phenoxy
hydroxy
preparation
new
Prior art date
Application number
CH1843568A
Other languages
German (de)
English (en)
Inventor
Herbert Dr Koeppe
Werner Dr Kummer
Helmut Dr Staehle
Zeile Karl Dr Prof
Albrecht Dr Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Priority to CH847971A priority Critical patent/CH532019A/de
Priority to CH847671A priority patent/CH532016A/de
Priority to CH848371A priority patent/CH515885A/de
Priority to CH848271A priority patent/CH530956A/de
Priority to CH848171A priority patent/CH530955A/de
Priority to CH847871A priority patent/CH532018A/de
Priority to CH848571A priority patent/CH530957A/de
Priority to CH848071A priority patent/CH530954A/de
Priority to CH847771A priority patent/CH532017A/de
Publication of CH532015A publication Critical patent/CH532015A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH1843568A 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen CH532015A (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CH847971A CH532019A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH847671A CH532016A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH848371A CH515885A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH848271A CH530956A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH848171A CH530955A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH847871A CH532018A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH848571A CH530957A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH848071A CH530954A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH847771A CH532017A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1643262A DE1643262C3 (de) 1967-12-13 1967-12-13 i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH532015A true CH532015A (de) 1972-12-31

Family

ID=5684274

Family Applications (2)

Application Number Title Priority Date Filing Date
CH848471A CH556816A (de) 1967-12-13 1968-12-10 Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy-3-alkylaminopropanen.
CH1843568A CH532015A (de) 1967-12-13 1968-12-10 Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH848471A CH556816A (de) 1967-12-13 1968-12-10 Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy-3-alkylaminopropanen.

Country Status (21)

Country Link
US (1) US3872147A (fi)
JP (1) JPS5220457B1 (fi)
AT (13) AT292679B (fi)
BE (1) BE725490A (fi)
BG (9) BG17298A3 (fi)
BR (1) BR6804840D0 (fi)
CA (1) CA954528A (fi)
CH (2) CH556816A (fi)
DE (1) DE1643262C3 (fi)
DK (1) DK131029B (fi)
ES (11) ES361189A1 (fi)
FI (1) FI49497C (fi)
FR (2) FR1596100A (fi)
GB (1) GB1260866A (fi)
HU (1) HU162734B (fi)
IE (1) IE32758B1 (fi)
IL (1) IL31266A (fi)
NL (3) NL146709B (fi)
PH (1) PH9266A (fi)
SE (1) SE367396B (fi)
YU (12) YU33949B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3998874A (en) * 1971-03-23 1976-12-21 Gist-Brocades N.V. Phenylene di-ethers
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4094991A (en) * 1975-06-17 1978-06-13 Nippon Shinyaku Co., Ltd. Substituted n-(carboxymethyl)-3-aminopropan-2-ol derivatives
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
JPS56142262A (en) 1980-04-08 1981-11-06 Nippon Shinyaku Co Ltd Piperazine derivative
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3131527A1 (de) * 1981-08-08 1983-02-24 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0720861B2 (ja) * 1984-04-09 1995-03-08 ザ デュポン マーク ファーマソウテイカル カンパニー 心臓障害の処置または予防用の医薬組成物および方法
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
ES2011255B3 (es) * 1985-12-24 1990-01-01 Merck & Co Inc Bloqueadores beta selectivos para los ojos.
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Also Published As

Publication number Publication date
YU237874A (en) 1977-12-31
GB1260866A (en) 1972-01-19
BG16329A3 (bg) 1972-08-20
CH556816A (de) 1974-12-13
ES375453A1 (es) 1972-05-16
YU237774A (en) 1978-02-28
NL6817768A (fi) 1969-06-17
YU237674A (en) 1977-10-31
ES375444A1 (es) 1972-05-01
DE1643262B2 (de) 1974-11-07
ES375448A1 (es) 1972-05-01
ES375449A1 (es) 1972-05-01
YU238374A (en) 1977-12-31
IE32758B1 (en) 1973-11-28
BG16444A3 (bg) 1972-11-20
YU294968A (en) 1978-02-28
YU237574A (en) 1978-02-28
AT292674B (de) 1971-09-10
SE367396B (fi) 1974-05-27
FI49497C (fi) 1975-07-10
HU162734B (fi) 1973-04-28
YU33855B (en) 1978-06-30
AT292679B (de) 1971-09-10
AT292678B (de) 1971-09-10
DK131029C (fi) 1975-10-06
YU33852B (en) 1978-06-30
NL7501794A (nl) 1975-05-30
DK131029B (da) 1975-05-20
FR1596100A (fi) 1970-06-15
YU33773B (en) 1978-05-15
AT292680B (de) 1971-09-10
IL31266A (en) 1974-09-10
AT292673B (de) 1971-09-10
AT292675B (de) 1971-09-10
ES361189A1 (es) 1970-08-16
ES375451A1 (es) 1972-05-01
ES375445A1 (es) 1972-05-16
BG19135A3 (fi) 1975-04-30
DE1643262C3 (de) 1975-06-26
YU33853B (en) 1978-06-30
FR8328M (fi) 1970-12-07
BG16332A3 (bg) 1972-08-20
PH9266A (en) 1975-07-30
BG16445A3 (bg) 1972-11-20
FI49497B (fi) 1975-04-01
CA954528A (en) 1974-09-10
YU238174A (en) 1977-10-31
AT298459B (de) 1972-05-10
YU33946B (en) 1978-09-08
AT292677B (de) 1971-09-10
AT298463B (de) 1972-05-10
YU238474A (en) 1978-02-28
ES375446A1 (es) 1972-05-01
NL151354B (nl) 1976-11-15
ES375447A1 (es) 1972-05-01
YU237474A (en) 1977-12-31
YU33947B (en) 1978-09-08
BG16331A3 (bg) 1972-08-20
AT292670B (de) 1971-09-10
YU237974A (en) 1977-12-31
YU33774B (en) 1978-05-15
NL7501792A (nl) 1975-05-30
DE1643262A1 (de) 1972-04-20
US3872147A (en) 1975-03-18
BR6804840D0 (pt) 1973-03-08
YU33854B (en) 1978-06-30
YU33851B (en) 1978-06-30
AT292676B (de) 1971-09-10
NL146709B (nl) 1975-08-15
BE725490A (fi) 1969-06-13
BG16330A3 (bg) 1972-08-20
ES375450A1 (es) 1972-05-01
YU33856B (en) 1978-06-30
BG17298A3 (fi) 1973-07-25
YU33948B (en) 1978-09-08
AT292681B (de) 1971-08-15
YU238274A (en) 1977-12-31
IL31266A0 (en) 1969-02-27
ES375452A1 (es) 1972-05-16
AT294799B (de) 1971-12-10
JPS5220457B1 (fi) 1977-06-03
BG17297A3 (fi) 1973-07-25
YU33949B (en) 1978-09-08
IE32758L (en) 1969-06-13
YU238074A (en) 1977-12-31

Similar Documents

Publication Publication Date Title
AT299171B (de) Verfahren zur Herstellung von neuen Bis-stilben-Verbindungen
CH532015A (de) Verfahren zur Herstellung von neuen 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
AT277221B (de) Verfahren zur Herstellung von neuen 5-Nitro-2-furyl-2-isoxazolin-derivaten
CH536313A (de) Verfahren zur Herstellung von neuen 2-Cycloalkyl-heteroaryl-Verbindungen
AT296983B (de) Verfahren zur Herstellung von neuen substituierten Benzodioxolen
AT277985B (de) Verfahren zur Herstellung von neuen Nitro-furan-, -thiophen- oder -pyrrol-derivaten
AT275517B (de) Verfahren zur Herstellung von neuen p-Alkoxy-piperidin-amiden
AT293440B (de) Verfahren zur Herstellung von neuen D-Glucofuranosiden
CH518936A (de) Verfahren zur Herstellung von neuen basisch substituierten bis-Piperidylalkanen
AT292684B (de) Verfahren zur Herstellung von neuen Naphthylisopropylaminen
AT291221B (de) Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen
CH493469A (de) Verfahren zur Herstellung von neuen Diarylacetamiden
AT281797B (de) Verfahren zur Herstellung von neuen Dialkylaminoacylaniliden
AT292022B (de) Verfahren zur Herstellung von neuen Disilacyclohexadienen
AT294124B (de) Verfahren zur Herstellung von neuen 6-Desoxy-D-xylohexafuranosiden
AT283319B (de) Verfahren zur Herstellung von neuen Azidozimtaldehyden
CH504451A (de) Verfahren zur Herstellung von neuen 3-Aminoacylaminothiophenen
AT277254B (de) Verfahren zur Herstellung von neuen Benzazepinopyridoindolderivaten
AT276408B (de) Verfahren zur Herstellung von neuen 2-Amino-3-carbonamido-chinoxalin-di-N-oxyden
AT294044B (de) Verfahren zur herstellung von neuen 2-alkoxy-5-chlorsulfonylnitrobenzolen
AT285830B (de) Verfahren zur Herstellung von neuen Morphin-3-acetamiden
AT281805B (de) Verfahren zur Herstellung von neuen 5-Nitrofurfurylidenaminooxazolidinonen
AT279606B (de) Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-2-imidazolonen
AT299976B (de) Verfahren zur Herstellung von neuen Disilacyclohexadienen
AT286959B (de) Verfahren zur Herstellung von neuen N-Cycloalkylmethylsäureamiden

Legal Events

Date Code Title Description
PL Patent ceased